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The authors would like to apologize for an error in the abstract. The sentence:

Ten FTLD-tau cases with a *MAPT* mutation (K257T, S3035S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of *MAPT* mutations from sporadic FTLD-tau is valid.

should read as follows:

Ten FTLD-tau cases with a *MAPT* mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of *MAPT* mutations from sporadic FTLD-tau is valid.

This error has been corrected online.
